Page last updated: 2024-08-16

propidium and alvocidib

propidium has been researched along with alvocidib in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Colevas, AD; Greer, J; Karp, JE; Mann, DL; Nakanishi, T; Ross, DD; Tidwell, ML; Wei, Y; Wright, JJ; Yang, W1
Motwani, M; Rizzo, C; Schwartz, GK; She, Y; Sirotnak, F1

Other Studies

2 other study(ies) available for propidium and alvocidib

ArticleYear
Timed sequential therapy of acute leukemia with flavopiridol: in vitro model for a phase I clinical trial.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2003, Volume: 9, Issue:1

    Topics: Adult; Aged; Antineoplastic Agents; Apoptosis; Bone Marrow Cells; Cell Division; Cell Survival; Coloring Agents; Female; Flavonoids; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Piperidines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Propidium; S Phase; Time Factors; Tumor Cells, Cultured

2003
Flavopiridol enhances the effect of docetaxel in vitro and in vivo in human gastric cancer cells.
    Molecular cancer therapeutics, 2003, Volume: 2, Issue:6

    Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; CDC2 Protein Kinase; Cell Cycle; Cell Line, Tumor; Cyclin B; Cyclin B1; Docetaxel; Drug Synergism; Enzyme Inhibitors; Flavonoids; Flow Cytometry; Humans; Immunoblotting; In Vitro Techniques; Mitosis; Neoplasm Transplantation; Piperidines; Propidium; Retinoblastoma Protein; Stomach Neoplasms; Taxoids; Time Factors

2003